Sponsor Pipeline

Actio Biosciences, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
1
Disease Areas
5
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-08 NCT07156201
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ABS-1230 Given…		 Enrollment increased: 74 -> 92 participants
2026-08-08 NCT07156201
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ABS-1230 Given…		 Trial arms changed: 5 -> 6
2026-08-08 NCT07156201
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ABS-1230 Given…		 date change Primary completion pushed: 2026-03 -> 2026-12
2026-08-08 NCT07156201
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ABS-1230 Given…		 date change Completion pushed: 2026-03 -> 2026-12
2026-08-08 NCT07600736
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity…		 Enrollment increased: 45 -> 55 participants
Active Trials by Phase
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07600736 A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity… KCNT1-Related Epilepsy Recruiting
Phase 1
NCT07156201 A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ABS-1230 Given… KCNT1-Related Epilepsy Recruiting
Disease Areas
Epilepsy (2)
Get alerts when Actio Biosciences, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free